<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>The Nevada National Board Professional Learning Institute | Bentzen | Activity</title>
	<link>http://www.nationalboardinstitute.com/members/mousedomain48/activity/</link>
	<atom:link href="http://www.nationalboardinstitute.com/members/mousedomain48/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Bentzen.</description>
	<lastBuildDate>Fri, 23 May 2025 17:06:54 -0700</lastBuildDate>
	<generator>https://buddypress.org/?v=9.1.1</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">cd6d54ac9fa501a248b80f4e8ad05a63</guid>
				<title>Bentzen posted an update: 9; 95% CI (3-35); p less then 0.001). Secondary elevation of [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/42185/</link>
				<pubDate>Sun, 09 Feb 2025 08:04:19 -0800</pubDate>

									<content:encoded><![CDATA[<p>9; 95% CI (3-35); p less then 0.001). Secondary elevation of S100B protein serum levels is associated with secondary infarction in ruptured brain arteriovenous malformations.Cancer alters cell metabolism. How these changes are manifested in the metabolite cargo of cancer-derived extracellular vesicles (EVs) remains poorly understood. To explore&hellip;<span class="activity-read-more" id="activity-read-more-42185"><a href="http://www.nationalboardinstitute.com/activity/p/42185/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">fb287d77f26f037c5a29eebd2e27aeec</guid>
				<title>Bentzen posted an update: 1 K). Ipilimumab clinical trial The obtained results can be [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/40556/</link>
				<pubDate>Fri, 07 Feb 2025 08:05:11 -0800</pubDate>

									<content:encoded><![CDATA[<p>1 K). <a href="https://www.selleckchem.com/products/ipilimumab.html" rel="nofollow ugc">Ipilimumab clinical trial</a> The obtained results can be useful for the design of novel contactless luminescence thermometers.Wettability-defined liquid infiltration into porous materials in nature and several industrial applications is of fundamental interest. Direct observation of wetting-controlled imbibition in mesopores is anticipated to&hellip;<span class="activity-read-more" id="activity-read-more-40556"><a href="http://www.nationalboardinstitute.com/activity/p/40556/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">362a02c9972fef5212f231d8cfea4a4b</guid>
				<title>Bentzen posted an update: 73. An improvement of ≥2 points on the PGI-S defined a t [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/34347/</link>
				<pubDate>Fri, 31 Jan 2025 08:05:52 -0800</pubDate>

									<content:encoded><![CDATA[<p>73. An improvement of ≥2 points on the PGI-S defined a treatment responder, based on comparison to the ISI definition of a responder (improvement of ≥6 points). Our present findings suggest that the PGI-S is a simple but valid, reliable, responsive, sensitive, and meaningful patient-reported assessment of insomnia severity. The PGI-S may be par&hellip;<span class="activity-read-more" id="activity-read-more-34347"><a href="http://www.nationalboardinstitute.com/activity/p/34347/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">79772e9af17d7563581298b1d8570eb9</guid>
				<title>Bentzen posted an update: Hardy-Weinberg Equilibrium tests and the comparison of [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/31062/</link>
				<pubDate>Tue, 28 Jan 2025 16:07:19 -0800</pubDate>

									<content:encoded><![CDATA[<p>Hardy-Weinberg Equilibrium tests and the comparison of obtained haplotype frequencies with the ones available from the 1000 Genome Project further supported the reliability of PERHAPS. Notably, we were able to determine the existence of the rare APOE*1 haplotype in two unrelated African subjects from UKBB, supporting its presence at appreciable&hellip;<span class="activity-read-more" id="activity-read-more-31062"><a href="http://www.nationalboardinstitute.com/activity/p/31062/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">89bc5fa88a01b80f5d0edaee8bf172b8</guid>
				<title>Bentzen became a registered member</title>
				<link>http://www.nationalboardinstitute.com/activity/p/31043/</link>
				<pubDate>Tue, 28 Jan 2025 16:06:06 -0800</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>